In an Axios article, mergers & acquisitions partner Emily Oldshue discussed the strong growth in biotechnology and pharmaceutical industry transactions, despite economic and geopolitical risks.
The article notes that Ropes & Gray advised Eli Lilly in a transaction to acquire psychedelic drug developer AtaiBeckley Inc. for up to $3.8 billion, expanding Lilly’s neurology pipeline to develop treatments for depression and other mental health disorders.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.